Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Lymph Node Excision
  • Neoplasms, Germ Cell and Embryonal
  • Testicular Neoplasms

abstract

  • Patients with advanced NSGCT have long-term freedom from disease progression when chemotherapy is combined with resection of residual masses. Our data suggest that the tumour response to chemotherapy, coupled with complete resection of all residual masses, predicts long-term freedom from disease progression.

publication date

  • May 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2007.06740.x

PubMed ID

  • 17437432

Additional Document Info

start page

  • 993

end page

  • 7

volume

  • 99

number

  • 5